Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • JDSwenson
    Junior Member
    • Apr 2016
    • 8

    #1

    Size Selection after fragmentation

    Hey there,

    This is my first post here - thanks for reading it!

    I'm rather lost. I'm prepping some samples for RNA-Seq, but in all four of my samples, I lose ~80-90% of my product at the mRNA fragmentation and cleanup step. I am using eukaryotic mRNA and am fragmenting with heat (94 C for 5 minutes) as per the protocol of the kit I'm using, which says these setting are ideal for fragmenting eukaryotic mRNA into 200 bp fragments.

    After fragmentation, I am doing a clean-up of the mRNA using 1.8X AmPure XP beads. Somewhere during these two steps I am dropping from ~ 5 ng/ul mRNA to 0.8 ng/ul fragmented mRNA, on average as demonstrated by BioAnalyzer, with some of my samples dropping to dangerously low levels (.2 ng/ul). The average size of my fragments is ~ 100-150 bp.

    Any idea why I'm losing so much product?

    My goal for the fragment size is 200 bp and I'd like to retain as much of it as possible (obviously). I'm thinking my next step should be to decrease the amount of time at 94 C to 4 minutes and to increase the concentration of AmPure to 2.4X, but I would greatly appreciate any feedback.
  • nucacidhunter
    Jafar Jabbari
    • Jan 2013
    • 1250

    #2
    Most kits do not cleanup fragmented RNA and go straight to 1st strand synthesis which avoids any loss. I would not use such a kit. AMPure XP bead is not suitable for RNA and may result in RNA degradation. It meant to be used for DNA.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    28 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-13-2026, 09:56 AM
    0 responses
    31 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-09-2026, 11:14 AM
    0 responses
    29 views
    0 reactions
    Last Post SEQadmin2  
    Working...